Researchers find link between chemotherapy during childhood and cognitive problems later in life

NewsGuard 100/100 Score

Young adults who had chemotherapy as a child have decreased cognitive flexibility and a weaker short-term memory. Their ability to concentrate and long-term memory are largely unaffected. Researchers from KU Leuven (University of Leuven) and University Hospitals Leuven present these findings in the Journal of the National Cancer Institute.

The researchers examined 31 young adults who underwent chemotherapy as a child - on average around the age of six and a half. They compared these survivors' performance on a number of psychological tests with the results of a control group.

The results show that cognitive functions such as long-term memory and the ability to concentrate are largely unaffected. These skills had already developed before the treatment. But the cancer treatment has an impact on several skills developed later on.

Slowly developing functions, in particular, are very vulnerable. "Tests that require quick switching between tasks or remembering new information for a short amount of time were clearly more difficult for former cancer patients. The developmental stage of the brain at the start of the cancer treatment probably plays a decisive role," psychiatrist in training Iris Elens and Professor Rudi D'Hooge explain.

The researchers also found a link between cognitive performance and the levels of one particular protein in the brain fluid: phosphorylated Tau (p-Tau), which is part of the internal structure of our nerve cells.

"Our team collected samples of brain fluid during the cancer treatment. We analyzed the p-Tau levels to measure the damage to the brain cells," Professor D'Hooge explains. "We found that high concentrations of p-Tau predict cognitive problems at a later age."

"If we systematically measure these p-Tau levels in the future," Iris Elens continues, "we can offer specific help to children with high values. With early coaching aimed at the most relevant functions, we can prevent problems that would otherwise manifest 10 to 15 years after the treatment."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Lancet Commission on Breast Cancer: Transforming breast cancer care globally